Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant

Transpl Int. 2015 Apr;28(4):502. doi: 10.1111/tri.12477.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Liver Transplantation / methods*
  • Male
  • Neoplasm Recurrence, Local / prevention & control*
  • Sirolimus / administration & dosage*
  • Sirolimus / analogs & derivatives*

Substances

  • Immunosuppressive Agents
  • Sirolimus